BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 2380576)

  • 1. Use of DAPI cytofluorometric analysis of cellular DNA content to differentiate Spitz nevus from malignant melanoma.
    Chi HI; Ishibashi Y; Shima A; Mihara I; Otsuka F
    J Invest Dermatol; 1990 Aug; 95(2):154-7. PubMed ID: 2380576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful differentiation of Spitz naevus from malignant melanoma by microfluorometric analysis of cellular DNA content.
    Otsuka F; Chi HI; Umebayashi Y
    Clin Exp Dermatol; 1993 Sep; 18(5):421-4. PubMed ID: 8252762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of image analysis with flow cytometry for DNA content analysis in pigmented lesions of the skin.
    Sangueza OP; Hyder DM; White CR; Pallander J; Perkins M; Remple N; Bakke A
    Anal Quant Cytol Histol; 1992 Feb; 14(1):55-9. PubMed ID: 1558616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p16 expression: a marker of differentiation between childhood malignant melanomas and Spitz nevi.
    Al Dhaybi R; Agoumi M; Gagné I; McCuaig C; Powell J; Kokta V
    J Am Acad Dermatol; 2011 Aug; 65(2):357-363. PubMed ID: 21550132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of DNA ploidy in dysplastic and Spitz nevi by flow cytometry.
    Winokur TS; Palazzo JP; Johnson WC; Duray PH
    J Cutan Pathol; 1990 Dec; 17(6):342-7. PubMed ID: 2074280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclin D1 overexpression in Spitz nevi: an immunohistochemical study.
    Nagasaka T; Lai R; Medeiros LJ; Brynes RK; McCourty A; Harada T; Saddik M
    Am J Dermatopathol; 1999 Apr; 21(2):115-20. PubMed ID: 10218669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative study of Spitz nevus and nodular malignant melanoma using image analysis cytometry.
    LeBoit PE; Van Fletcher H
    J Invest Dermatol; 1987 Jun; 88(6):753-7. PubMed ID: 3295064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spitz nevi.
    Casso EM; Grin-Jorgensen CM; Grant-Kels JM
    J Am Acad Dermatol; 1992 Dec; 27(6 Pt 1):901-13. PubMed ID: 1479095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multivariate DNA cytometry discriminates between Spitz nevi and malignant melanomas because large polymorphic nuclei in Spitz nevi are not aneuploid.
    Vogt T; Stolz W; Glässl A; Abmayr W; Hohenleutner U; Schmoeckel C; Schiffner R; Landthaler M
    Am J Dermatopathol; 1996 Apr; 18(2):142-50. PubMed ID: 8739988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differentiation between Spitz nevi and malignant melanomas by interphase fluorescence in situ hybridization.
    Wettengel GV; Draeger J; Kiesewetter F; Schell H; Neubauer S; Gebhart E
    Int J Oncol; 1999 Jun; 14(6):1177-83. PubMed ID: 10339676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significance of DNA ploidy measurements in Spitz nevi.
    Skowronek J; Warchoł JB; Karaś Z; Krenz RM
    Pol J Pathol; 2000; 51(1):45-50. PubMed ID: 10833903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA-cytophotometry of benign compound and intradermal naevi, Spitz epithelioid naevi and malignant melanomas.
    Lindholm C; Bjelkenkrantz K; Hofer PA
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1987; 53(4):257-8. PubMed ID: 2890239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. S100 protein, neurone specific enolase, and nuclear DNA content in Spitz naevus.
    Rode J; Williams RA; Jarvis LR; Dhillon AP; Jamal O
    J Pathol; 1990 May; 161(1):41-5. PubMed ID: 2370597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of pHH3, Ki-67, and survivin immunoreactivity in benign and malignant melanocytic lesions.
    Nasr MR; El-Zammar O
    Am J Dermatopathol; 2008 Apr; 30(2):117-22. PubMed ID: 18360113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nevoid malignant melanoma: morphologic patterns and immunohistochemical reactivity.
    McNutt NS; Urmacher C; Hakimian J; Hoss DM; Lugo J
    J Cutan Pathol; 1995 Dec; 22(6):502-17. PubMed ID: 8835170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Silhouette symmetry: an unsupportable histologic criterion for distinguishing Spitz nevi and compound nevi from malignant melanoma.
    Okun MR
    Arch Pathol Lab Med; 1997 Jan; 121(1):48-53. PubMed ID: 9111092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nucleolar organizer regions in pigmented skin lesions. Value in the differential diagnosis of Spitz nevi.
    González-Cámpora R; Armas-Padrón JR; Rios-Martín JJ; López-Garrido J; Gómez-Pascual A; Galera-Davidson H
    Anal Quant Cytol Histol; 1991 Feb; 13(1):16-22. PubMed ID: 1709022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pigmented Spitz nevi: improvement of the diagnostic accuracy by epiluminescence microscopy.
    Steiner A; Pehamberger H; Binder M; Wolff K
    J Am Acad Dermatol; 1992 Nov; 27(5 Pt 1):697-701. PubMed ID: 1430390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient age in Spitz nevus and malignant melanoma: implication of Bayes rule for differential diagnosis.
    Vollmer RT
    Am J Clin Pathol; 2004 Jun; 121(6):872-7. PubMed ID: 15198360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene Expression Analysis Differentiates Melanomas from Spitz Nevi.
    Jansen B; Hansen D; Moy R; Hanhan M; Yao Z
    J Drugs Dermatol; 2018 May; 17(5):574-576. PubMed ID: 29742191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.